tiprankstipranks
Trending News
More News >
CanSino Biologics, Inc. Class H (HK:6185)
:6185
Advertisement

CanSino Biologics, Inc. Class H (6185) Revenue

Compare
4 Followers

CanSino Biologics, Inc. Class H Revenue

CanSino Biologics, Inc. Class H had a revenue of 245.17M in the quarter ending Jun 30, 2025, with 78.75%. This bring the company's revenue in the last twelve months to 925.24M, Decreased 8.70%. In the fiscal year ending Dec 31, 2024, CanSino Biologics, Inc. Class H had annual revenue of 846.34M with 145.19% growth.
Revenue (ttm)
925.24M
Revenue Growth
45.19%
P/S Ratio
15.54
Revenue/Employee
HK$765,917
Employees
1,105
Market Cap
HK$13.15B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
846.34M501.16M+245.19%
Dec 31, 2023
345.18M-685.86M+33.48%
Dec 31, 2022
1.03B-3.27B+23.98%
Dec 31, 2021
4.30B4.27B+17,274.82%
Dec 31, 2020
24.89M22.61M+1,090.05%
Dec 31, 2019
2.28M1.15M+201.71%
Dec 31, 2018
1.13M-8.05M+12.33%
Dec 31, 2017
9.18M987.00K+112.04%
Dec 31, 2016
8.20M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis